Theravance Biopharma, Inc. - Ordinary Shares (TBPH) Social Stream
THERAVANCE BIOPHARMA INC (TBPH) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering THERAVANCE BIOPHARMA INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 7 | $20 | $8 | $12.444 | $10.37 | 20% |
| 2022-02-11 | 6 | $20 | $8 | $12.625 | $10.37 | 21.75% |
| 2022-02-25 | 6 | $18 | $9 | $12.142 | $10.37 | 17.09% |
| 2022-03-02 | 6 | $18 | $9 | $12.428 | $10.37 | 19.85% |
| 2022-04-19 | 6 | $18 | $9 | $12.285 | $10.37 | 18.47% |
| 2022-05-09 | 4 | $18 | $8 | $12.142 | $10.37 | 17.09% |
| 2022-05-10 | 4 | $18 | $8 | $12 | $10.37 | 15.72% |
| 2022-05-23 | 5 | $18 | $8 | $12 | $10.37 | 15.72% |
| 2022-07-25 | 5 | $18 | $8 | $11.857 | $10.37 | 14.34% |
| 2022-08-13 | 5 | $18 | $9 | $12 | $10.37 | 15.72% |
| 2022-10-21 | 5 | $14 | $9 | $11 | $10.37 | 6.08% |
| 2022-11-11 | 5 | $19 | $9 | $12.221 | $10.37 | 17.85% |
| 2022-11-17 | 5 | $19 | $9 | $12.555 | $10.37 | 21.07% |
| 2022-11-21 | 5 | $19 | $9 | $12.555 | $10.37 | 21.07% |
| 2023-01-26 | 5 | $19 | $9 | $12.266 | $10.37 | 18.28% |
| 2023-02-28 | 5 | $19 | $9.33 | $12.466 | $10.37 | 20.21% |
| 2023-04-21 | 5 | $19 | $9 | $12.4 | $10.37 | 19.58% |
| 2023-05-10 | 4 | $19 | $9 | $13 | $10.37 | 25.36% |
| 2023-11-08 | 4 | $20 | $9 | $13.25 | $10.37 | 27.77% |
| 2023-11-09 | 4 | $20 | $10 | $13.5 | $10.37 | 30.18% |
The Trend in the Analyst Price Target
TBPH's average price target has moved up $2.5 over the prior 14 months.
TBPH reports an average of 18.53% for its upside potential over the past 41 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-26 | 5 | 19 | 9.00 | 12.266 | 10.67 | 14.96% |
| 2023-01-27 | 5 | 19 | 9.33 | 12.466 | 10.87 | 14.68% |
| 2023-04-21 | 4 | 19 | 9.00 | 13.000 | 11.56 | 12.46% |
| 2023-08-08 | 4 | 20 | 9.00 | 13.250 | 9.74 | 36.04% |
| 2023-11-08 | 4 | 20 | 9.00 | 13.250 | 10.25 | 29.27% |
TBPH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.25 | 2 | 0 | 1 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 25 months, TBPH's average broker recommendation rating improved by 0.64.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- TBPH has a higher average analyst price target than 325.84% of all US stocks.
- In terms of how THERAVANCE BIOPHARMA INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1736.43% of that group.
- To contextualize these metrics, consider that out of all US stocks, THERAVANCE BIOPHARMA INC's number of analysts covering the stock is greater than 497.55% of them.
- In the context of Pharmaceutical Products stocks, THERAVANCE BIOPHARMA INC's upside potential (average analyst target price relative to current price) is greater than 500.78% of them.
In the Pharmaceutical Products industry, PRTA, AGIO, and ESPR are the three stocks most similar to THERAVANCE BIOPHARMA INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is TBPH a Buy, Hold or Sell? See the POWR Ratings now!